Help patients save on KERYDIN®!

The PharmaDerm RxSaver Program provides benefits for PharmaDerm-branded therapies like KERYDIN®, including:

  • A copay as low as $25*
  • The ability for your practice to eScribe to a participating program pharmacy:
    •  CareMed at 877-227-3405
    •  RxCrossroads at 502-213-1408
    •  Participating program pharmacies may be able to provide patients with other affordability solutions

PharmaDerm RxSaver Program Card     

               KERYDIN® (tavaborole) 4-mL and 10-mL bottles with dropper
             

Instruct patients to visit PharmaDerm.com to enroll in the program.

*
Eligibility and restrictions 1. Limitations apply. 2. Valid only for those with commercial insurance. 3. Not valid if prescriptions are paid in part or in full by any state or federally funded healthcare program. 4. Not valid for cash paying patients who have no commercial insurance or where plan reimburses you for the entire cost of your prescription drug. 5. Offer is not valid where prohibited by law. 6. Valid only for residents of the US and Puerto Rico. 7. This program is not health insurance. 8. Offer may not be combined with any other rebate, coupon, or offer. 9. This card is the property of PharmaDerm, a division of Fougera Pharmaceuticals Inc. and must be returned upon request. 10. Fougera reserves the right to rescind, revoke, or amend the program without notice. 11. Patient certifies responsibility for complying with applicable limitations, if any, or any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. 12. Acceptance of this card and your submission of claims for the PharmaDerm RxSaver Program are subject to the LoyaltyScript® program Terms and Conditions established by McKesson Corporation. 13. This card has no cash value. 14. This Offer expires on December 31, 2018. For any questions regarding set up, claims transmission, patient eligibility or other issues, call the PharmaDerm RxSaver Program at 1-844-396-8097 (8am-8pm ET, Monday-Friday).

Important Safety Information

KERYDIN® (tavaborole) is for topical use only and not for oral, ophthalmic, or intravaginal use. The most commonly reported adverse events involved skin reactions in the application area, including exfoliation, ingrown toenail, erythema, and dermatitis. 

Safety and effectiveness have not been established in pregnant or breastfeeding women or pediatric patients.

See Full Prescribing Information for KERYDIN®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Indication

KERYDIN® is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.

Important Safety Information

KERYDIN® (tavaborole) is for topical use only and not for oral, ophthalmic, or intravaginal use. The most commonly reported adverse events involved skin reactions in the application area, including exfoliation, ingrown toenail, erythema, and dermatitis. 

Safety and effectiveness have not been established in pregnant or breastfeeding women or pediatric patients.

See Full Prescribing Information for KERYDIN®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Indication

KERYDIN® is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.

Rotate your phone for Important Safety Information.

You are now leaving the KERYDIN® website. PharmaDerm does not endorse the content of third-party websites. Would you like to continue?